CAS Medical Systems Inc. widened its second-quarter loss on a drop in global sales of the Branford biotech’s blood-oxygen sensors.
For three months ended June 30, CAS Med lost a net $1.9 million, or 15 cents a share, greater than the $1.4 million, or 11 cents a share, lost the year-ago period.
Second-quarter sales were $5.2 million vs. $5.7 million a year ago.
President and CEO Thomas M. Patton said its investment in expanding its global sales force boosted revenues from its Fore-Sight disposable sensors by 45 percent in the quarter.
ADVERTISEMENT
But sales lagged in its traditional monitoring products, Patton said.
